Direct circulating tumor DNA detection from unpurified plasma using a digital PCR platform

Clinical Biochemistry

Volumn 50, Issue 16-17, 2017, Pages 963-966

  Sefrioui, David ^a   Beaussire, Ludivine ^a   Perdrix, Anne ^a   Clatot, Florian ^a   Michel, Pierre ^a   Frebourg, Thierry ^a   Di Fiore, Frédéric ^a   Sarafan Vasseur, Nasrin ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Circulating tumor DNA; Digital PCR; Metastastic colorectal cancer; Unpurified plasma

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; CIRCULATING TUMOR DNA; DNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; GENE FREQUENCY; HUMAN; LIMIT OF DETECTION; METASTATIC COLORECTAL CANCER; ONCOGENE K RAS; ONCOGENE N RAS; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; COLORECTAL NEOPLASMS; GENETICS; METASTASIS; MUTATION; PATHOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; TUMOR GENE;

BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; DNA, NEOPLASM; GENES, NEOPLASM; HUMANS; MUTATION; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 85021682266     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2017.06.005     Document Type: Article

References (14)

1. Sefrioui, D., Sarafan-Vasseur, N., Beaussire, L., Baretti, M., Gangloff, A., Blanchard, F., Clatot, F., Sabourin, J.-C., Sesboüé, R., Frebourg, T., Michel, P., Di Fiore, F., Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer. Dig. Liver Dis. 47 (2015), 884–890.
2. Sefrioui, D., Perdrix, A., Sarafan-Vasseur, N., Dolfus, C., Dujon, A., Picquenot, J.-M., Delacour, J., Cornic, M., Bohers, E., Leheurteur, M., Rigal, O., Tennevet, I., Thery, J.-C., Alexandru, C., Guillemet, C., Moldovan, C., Veyret, C., Frebourg, T., Di Fiore, F., Clatot, F., Short report: monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer. Int. J. Cancer 137 (2015), 2513–2519.
3. Clatot, F., Perdrix, A., Augusto, L., Beaussire, L., Delacour, J., Calbrix, C., Sefrioui, D., Viailly, P.-J., Bubenheim, M., Moldovan, C., Alexandru, C., Tennevet, I., Rigal, O., Guillemet, C., Leheurteur, M., Gouérant, S., Petrau, C., Théry, J.-C., Picquenot, J.-M., Veyret, C., Frébourg, T., Jardin, F., Sarafan-Vasseur, N., Di Fiore, F., Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor. Oncotarget 7 (2016), 74448–74459.
4. El Messaoudi, S., Rolet, F., Mouliere, F., Thierry, A.R., Circulating cell free DNA: preanalytical considerations. Clin. Chim. Acta 424 (2013), 222–230.
5. Barra, G.B., Santa Rita, T.H., de Vasques, J.A., Chianca, C.F., Nery, L.F.A., Costa, S.S.S., EDTA-mediated inhibition of DNases protects circulating cell-free DNA from ex vivo degradation in blood samples. Clin. Biochem. 48 (2015), 976–981.
6. Kang, Q., Henry, N.L., Paoletti, C., Jiang, H., Vats, P., Chinnaiyan, A.M., Hayes, D.F., Merajver, S.D., Rae, J.M., Tewari, M., Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes. Clin. Biochem. 49 (2016), 1354–1360.
7. Breitbach, S., Tug, S., Helmig, S., Zahn, D., Kubiak, T., Michal, M., Gori, T., Ehlert, T., Beiter, T., Simon, P., Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS One, 9, 2014, e87838.
8. Sonnenberg, A., Marciniak, J.Y., Rassenti, L., Ghia, E.M., Skowronski, E.A., Manouchehri, S., McCanna, J., Widhopf, G.F., Kipps, T.J., Heller, M.J., Rapid electrokinetic isolation of cancer-related circulating cell-free DNA directly from blood. Clin. Chem. 60 (2014), 500–509.
9. Hudecova, I., Digital PCR analysis of circulating nucleic acids. Clin. Biochem. 48 (2015), 948–956.
10. Sefrioui, D., Mauger, F., Leclere, L., Beaussire, L., Di Fiore, F., Deleuze, J.-F., Sarafan-Vasseur, N., Tost, J., Comparison of the quantification of KRAS mutations by digital PCR and E-ice-COLD-PCR in circulating-cell-free DNA from metastatic colorectal cancer patients. Clin. Chim. Acta 465 (2016), 1–4.
11. Xia, P., Radpour, R., Kohler, C., Dang, C.X., Fan, A.X.C., Holzgreve, W., Zhong, X.Y., A selected pre-amplification strategy for genetic analysis using limited DNA targets. Clin. Chem. Lab. Med. 47 (2009), 288–293.
12. Jackson, J.B., Choi, D.S., Luketich, J.D., Pennathur, A., Ståhlberg, A., Godfrey, T.E., Multiplex preamplification of serum DNA to facilitate reliable detection of extremely rare cancer mutations in circulating DNA by digital PCR. J. Mol. Diagn. 18 (2016), 235–243.
13. Jia, S., Zhang, R., Li, Z., Li, J., Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer. Oncotarget, 2017.
14. Siravegna, G., Marsoni, S., Siena, S., Bardelli, A., Integrating liquid biopsies into the management of cancer. Nat. Rev. Clin. Oncol., 2017.